Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
VKTX
#1285
Viking Therapeutics, Inc
33.8
4
+6.28%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+6.28%
Aylık değişim
+7.46%
6 aylık değişim
+25.94%
Yıllık değişim
+20.43%
Önceki kapanış
31.8
4
Open
33.8
4
Bid
Ask
Low
33.8
4
High
33.8
4
Hacim
112
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
VKTX
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
111.44 M
112.25 M
112.31 M
112.44 M
113.04 M
115.55 M
—
Valuation ratios
Enterprise value
7 B
4.49 B
2.67 B
2.95 B
2.87 B
3.9 B
12.39 B
Price to earnings ratio
-68.82
-39.84
-20.82
-17.21
-12.34
-11.03
-61.39
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
-88.45
-49.98
-19.76
-19.26
-13.07
-14.22
-66.31
Price to book ratio
2.13
4.98
0.74
0.85
0.9
6.2
8.7
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.03
0.04
0.05
0.08
0.12
0.22
0.47
Return on equity %
0.03
0.04
0.05
0.08
0.13
0.25
0.51
Return on invested capital %
9 231.31
11.17 K
14.49 K
21.54 K
32.17 K
52.29 K
120.49 K
Gross margin %
—
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
36.47
33.09
44.25
25.86
28.34
9.33
107.78
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.2
0.29
0.47
0.42
0.84
0.76
2.48
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
8.39
8.28
7.6
7.2
6.36
6.26
27.43
Net current asset value per share
8.45
8.32
7.73
7.38
6.58
6.35
28.03
Tangible book value per share
8.22
8.07
7.56
7.09
6.35
5.67
26.67
Working capital per share
8.21
8.07
7.55
7.09
6.34
5.67
26.66
Book value per share
8.22
8.07
7.56
7.09
6.35
5.67
26.67
Haberler
Lilly's GLP-1 Blockbusters Drive 2025 Revenue Surge: What's Ahead?
Lilly vs. Novo Nordisk: Obesity Drug Giants' Face-Off in 2026
American Express, Oracle among market cap stock movers on Monday
Novo Nordisk Dives As Next-Gen Obesity Drug Lags Eli Lilly's Kingpin
Structure Therapeutics: The Dark Horse Has Taken The Lead - But Is It Enough? (GPCR)
Can LLY's Next-Gen Obesity Pipeline Sustain Growth Amid Competition?
Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk
NVO Crashes 21% in a Month: Is This an Indication to Sell the Stock?
Viking Therapeutics: Full-Speed Ahead (NASDAQ:VKTX)
Viking: Buyers Quietly Accumulating On Obesity Drugs Launch Potential (NASDAQ:VKTX)
Cisco and Micron among market cap stock movers on Thursday
How to Play Eli Lilly Stock Following a Robust Q4 Earnings Report